AMI Investment Management Inc. cut its holdings in UnitedHealth Group Inc (NYSE:UNH) by 2.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 5,886 shares of the healthcare conglomerate’s stock after selling 155 shares during the period. AMI Investment Management Inc.’s holdings in UnitedHealth Group were worth $1,466,000 at the end of the most recent reporting period.
Other institutional investors have also bought and sold shares of the company. Fagan Associates Inc. increased its position in shares of UnitedHealth Group by 2.7% during the fourth quarter. Fagan Associates Inc. now owns 1,433 shares of the healthcare conglomerate’s stock valued at $357,000 after buying an additional 38 shares during the period. Advisors Capital Management LLC increased its position in shares of UnitedHealth Group by 3.0% during the fourth quarter. Advisors Capital Management LLC now owns 1,480 shares of the healthcare conglomerate’s stock valued at $369,000 after buying an additional 43 shares during the period. NewSquare Capital LLC increased its position in shares of UnitedHealth Group by 15.6% during the fourth quarter. NewSquare Capital LLC now owns 333 shares of the healthcare conglomerate’s stock valued at $83,000 after buying an additional 45 shares during the period. SWS Partners increased its position in shares of UnitedHealth Group by 1.9% during the fourth quarter. SWS Partners now owns 2,446 shares of the healthcare conglomerate’s stock valued at $609,000 after buying an additional 45 shares during the period. Finally, Capital Investment Advisors LLC increased its position in shares of UnitedHealth Group by 0.9% during the fourth quarter. Capital Investment Advisors LLC now owns 5,389 shares of the healthcare conglomerate’s stock valued at $1,343,000 after buying an additional 48 shares during the period. 87.40% of the stock is owned by institutional investors and hedge funds.
UNH has been the topic of several research analyst reports. Cleveland Research reiterated a “buy” rating on shares of UnitedHealth Group in a research report on Friday, January 11th. Credit Suisse Group restated a “buy” rating and issued a $310.00 price objective on shares of UnitedHealth Group in a report on Friday, February 8th. Stephens initiated coverage on shares of UnitedHealth Group in a report on Monday, January 14th. They issued an “overweight” rating and a $287.00 price objective on the stock. Zacks Investment Research cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Tuesday, March 19th. Finally, Cantor Fitzgerald restated a “buy” rating and issued a $310.00 price objective on shares of UnitedHealth Group in a report on Tuesday, January 15th. One research analyst has rated the stock with a sell rating, two have issued a hold rating, eighteen have assigned a buy rating and one has given a strong buy rating to the stock. The company currently has an average rating of “Buy” and a consensus price target of $288.74.
Shares of NYSE:UNH traded down $0.50 during trading on Friday, reaching $231.95. 4,323,061 shares of the stock traded hands, compared to its average volume of 5,289,813. UnitedHealth Group Inc has a 52-week low of $208.07 and a 52-week high of $287.94. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.63. The stock has a market cap of $220.87 billion, a price-to-earnings ratio of 18.01, a PEG ratio of 1.25 and a beta of 0.74.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $3.73 EPS for the quarter, beating the Zacks’ consensus estimate of $3.60 by $0.13. The firm had revenue of $60.30 billion for the quarter, compared to analysts’ expectations of $59.72 billion. UnitedHealth Group had a net margin of 5.45% and a return on equity of 25.07%. The business’s revenue for the quarter was up 9.2% on a year-over-year basis. During the same quarter in the prior year, the company posted $3.04 earnings per share. As a group, sell-side analysts anticipate that UnitedHealth Group Inc will post 14.7 earnings per share for the current year.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Recommended Story: Call Option Volume
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.